nestle glp-1 products may complement weight-loss drugs Educational Resources | Nestlé Medical

This designation allows the use of research chemicals strictly for laboratory experimentation only

Here's the uncomfortable truth: up to 25-40% of the weight you lose on GLP-1 medications can be muscle, not fat

Mounjaro, Wegovy, Ozempic and Zepbound are given once per week as injections under the skin (subcutaneously) in the stomach area, thigh or upper arm

SREBP-1a has been identified as a potent transcriptional activator, with the capacity to promote both fatty acid and cholesterol synthesis

Because of these differences, having multiple GLP-1 medications available allows treatment to be individualised rather than forced into a one-size-fits-all approach

However, along with these risks come some anecdotal stories of unusual benefits that warrant research